Latest Merck & Co. Stories
SAN DIEGO and LEXINGTON, Mass., Dec.
The Society for Clinical Research Sites welcomes Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA as its newest Global Impact Partner ELLICOTT CITY, Md., Oct.
-- Bayer becomes the OTC leader in North and Latin America and achieves top global positions in key OTC categories -- Erica Mann heads Bayer's new consumer care business globally
The Emergence of Keytruda--the First PD-1 Inhibitor Approved in the U.S.--is a Significant Milestone in Oncology, According to Decision Resources Group BURLINGTON, Mass., Sept.
DUBLIN, Ireland, August 21, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/3zh3q8/global_hormone) has announced the addition of
CLEVELAND, July 23, 2014 /PRNewswire-USNewswire/ -- Juventas Therapeutics, a clinical-stage biotechnology company developing a first-in-class regenerative gene therapy for treatment of heart
- The act of sweetening by admixture of some saccharine substance.